{
  "actions": [
    {
      "acted_at": "1993-06-15", 
      "references": [
        {
          "reference": "CR S7234-7235", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "1993-06-15", 
      "committee": "Committee on Finance", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Finance.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s1106-103", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Finance", 
      "committee_id": "SSFI"
    }
  ], 
  "congress": "103", 
  "cosponsors": [
    {
      "district": null, 
      "name": "Daschle, Thomas A.", 
      "sponsored_at": "1993-06-15", 
      "state": "SD", 
      "thomas_id": "00267", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "1993-06-15", 
  "number": "1106", 
  "official_title": "A bill to amend certain provisions of title XVIII of the Social Security Act relating to end stage renal disease, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": null, 
  "sponsor": {
    "district": null, 
    "name": "Durenberger, Dave", 
    "state": "MN", 
    "thomas_id": "01321", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "1993-06-15", 
  "subjects": [
    "Health", 
    "Health insurance", 
    "Immunosuppressive drugs", 
    "Kidney diseases", 
    "Medicare", 
    "Transplantation of organs, tissues, etc."
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "1993-06-15", 
    "text": "Amends title XVIII (Medicare) of the Social Security Act to: (1) increase the period during which group health plans are the primary payers for dialysis treatment furnished to individuals with end stage renal disease (ESRD) who are newly eligible for Medicare part A (Hospital Insurance); and (2) extend to three years (starting after 1996), on a phased in, graduated basis, the current one-year period following a transplant procedure during which Medicare covers immunosuppresive drug therapy for Medicare beneficiaries who have received organ transplants. Amends the Omnibus Budget Reconciliation Act of 1986 to increase payments for dialysis treatments for ESRD patients."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "A bill to amend certain provisions of title XVIII of the Social Security Act relating to end stage renal disease, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:27:59-05:00"
}